Louisiana 2024 Regular Session

Louisiana House Bill HB403

Introduced
2/29/24  
Introduced
2/29/24  
Refer
2/29/24  
Refer
2/29/24  
Refer
3/11/24  
Refer
3/11/24  
Report Pass
3/18/24  
Report Pass
3/18/24  
Engrossed
3/20/24  
Engrossed
3/20/24  
Refer
3/25/24  
Refer
3/25/24  
Report Pass
4/22/24  
Report Pass
4/22/24  
Enrolled
5/8/24  
Enrolled
5/8/24  
Chaptered
5/15/24  
Chaptered
5/15/24  
Passed
5/15/24  

Caption

Adds drugs prescribed for certain ocular conditions to the listing of prescription drugs exempt from local sales and use taxes (EN DECREASE LF RV See Note)

Impact

If enacted, HB 403 will modify existing statutes regarding sales tax exemptions, particularly in the healthcare and pharmaceutical sectors. By exempting additional prescription drugs from local sales and use taxes, it aims to enhance accessibility and affordability for patients in need of treatments for certain eye conditions. This action aligns with broader efforts to improve healthcare affordability while recognizing the medical necessity of such treatments.

Summary

House Bill 403 focuses on the local sales and use tax exemptions for specific prescription drugs used in medical clinics. The bill proposes the addition of drugs that are prescribed for the treatment of cataracts and ocular inflammation or pain following ophthalmic surgery to the list of those exempt from local sales and use taxes. This legislation intends to decrease the financial burden on patients undergoing treatment for these ocular conditions by reducing the costs associated with these necessary medications.

Sentiment

The sentiment surrounding HB 403 appears to be largely positive, particularly among healthcare practitioners and patient advocacy groups. Supporters argue that the bill addresses critical health concerns and promotes better access to necessary medical treatments without the added financial strain of sales taxes. Nevertheless, there might be underlying discussions about the implications of tax exemptions on local revenues, which could introduce complexities in state funding that critics may highlight.

Contention

While there seems to be general support for the bill, notable points of contention may arise during discussions regarding its impact on local government revenues. Some legislators and local officials might voice concerns that expanding tax exemptions could reduce funds available for local services. Balancing the benefits of healthcare access against potential revenue loss will likely be a point of debate as the bill progresses through the legislative process.

Companion Bills

No companion bills found.

Previously Filed As

LA HB606

Exempts prescription drugs and insulin from local sales and use taxes (EG DECREASE LF RV See Note)

LA SB243

Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)

LA HB229

Exempts certain foods and beverages from local sales tax (OR DECREASE LF RV See Note)

LA HB578

Provides with respect to state and local sales and use taxes and exemptions to those taxes (EN DECREASE GF RV See Note)

LA SB707

Relating to exemption of prescription drug sales; prescribing an effective date.

LA HB2199

Relating to exemption of prescription drug sales; prescribing an effective date.

LA SB382

Relating to exemption of prescription drug sales; prescribing an effective date.

LA HB1698

Retail sales and use tax; exemption for prescription medicine and drugs purchased by veterinarians; sunset.

LA HB729

AN ACT proposing to create a new section of the Constitution of Kentucky relating to the exemption of state and local excise, sales, and use taxes from food, food ingredients, prescription drugs, and residential and on-farm utilities.

LA HB155

AN ACT proposing to create a new section of the Constitution of Kentucky relating to the exemption of state and local excise, sales, and use taxes from food, food ingredients, prescription drugs, and residential and on-farm utilities.

Similar Bills

No similar bills found.